| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000012678 |
| Receipt No. | R000014750 |
| Official scientific title of the study | Efficacy of capsule endoscopy on the diagnosis of advanced colorectal cancer which is detected by colonoscopy |
| Date of disclosure of the study information | 2013/12/25 |
| Last modified on | 2016/06/24 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Efficacy of capsule endoscopy on the diagnosis of advanced colorectal cancer which is detected by colonoscopy | |
| Title of the study (Brief title) | Efficacy of capsule endoscopy on the diagnosis of advanced colorectal cancer | |
| Region |
|
|
| Condition | ||||
| Condition | Advanced colorectal cancers | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Malignancy | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | To evaluate the efficacy of capsule endoscopy on the diagnosis of advanced colorectal cancer |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Detection rate of advanced colorectal cancer |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -but assessor(s) are blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | Colon capsule endoscopy | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patient with advanced colorectal cancer,which is diagnosed by conventional colonoscopy | |||
| Key exclusion criteria | Patients with severe stenosis in the colon
Patients with prior colectomy, colostomy or colonic stenting Patients with swallowing disorders Patients with pacemakers or other implanted electro medical devices Patients who could not perform surgery according to adverse general condition when complication was occurred Patients with allergy for polyethylene glycol, magnesium citrate, dimethicone, mosapride citrate, bisacodyl Patients with severe hepatic diseases Patients with severe renal diseases Patients with severe respiratory diseases Patients with severe cardiac diseases |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Atsuo Yamada |
| Organization | University of Tokyo |
| Division name | Department of Gastroenterology |
| Address | 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan |
| TEL | 03-3815-5411 |
| yamada-a@umin.ac.jp | |
| Public contact | |
| Name of contact person | Atsuo Yamada |
| Organization | University of Tokyo |
| Division name | Department of Gastroenterology |
| Address | 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan |
| TEL | 03-3815-5411 |
| Homepage URL | |
| yamada-a@umin.ac.jp | |
| Sponsor | |
| Institute | Department of Gastroentelorogy, University of Tokyo |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Given imaging K.K. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 東京大学医学部附属病院(東京都) University of Tokyo (Tokyo) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014750 |